News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

News|Videos|July 3, 2024

Shared Decision-Making for Patients With Mild/Moderate Multiple sclerosis

The panel reflects on their experiences as practicing clinicians, emphasizing the significance of shared decision-making and actively listening to patients’ preferences regarding management of their MS.

Episodes in this series

EP. 1 Presentation of Clinically Isolated Syndrome/First Attack of Multiple Sclerosis

EP. 1 Presentation of Clinically Isolated Syndrome/First Attack of Multiple Sclerosis

EP. 2 Defining Mild Multiple Sclerosis

EP. 2 Defining Mild Multiple Sclerosis

EP. 3 Mild/Moderate Multiple Sclerosis in Patients of Different Races and Ethnicities

EP. 3 Mild/Moderate Multiple Sclerosis in Patients of Different Races and Ethnicities

EP. 4 Conversations With Patients About Mild/Moderate Multiple Sclerosis

EP. 4 Conversations With Patients About Mild/Moderate Multiple Sclerosis

EP. 5 Monitoring Patients With Mild/Moderate Multiple Sclerosis

EP. 5 Monitoring Patients With Mild/Moderate Multiple Sclerosis

EP. 6 Shared Decision-Making for Patients With Mild/Moderate Multiple sclerosis

EP. 6 Shared Decision-Making for Patients With Mild/Moderate Multiple sclerosis

EP. 7 De-Escalation Strategies and Challenges With the Use of HET in Mild/Moderate Multiple Sclerosis

EP. 7 De-Escalation Strategies and Challenges With the Use of HET in Mild/Moderate Multiple Sclerosis

EP. 8 Choosing Between Moderate Therapies for Mild/Moderate Multiple Sclerosis

EP. 8 Choosing Between Moderate Therapies for Mild/Moderate Multiple Sclerosis

EP. 9 Treatment Adherence in Mild Multiple Sclerosis

EP. 9 Treatment Adherence in Mild Multiple Sclerosis

EP. 10 Benign Multiple Sclerosis

EP. 10 Benign Multiple Sclerosis

EP. 11 Diagnostic Uncertainty, Monitoring and Other Unmet Needs in Mild/Moderate Multiple Sclerosis

EP. 11 Diagnostic Uncertainty, Monitoring and Other Unmet Needs in Mild/Moderate Multiple Sclerosis

EP. 12 Generics and Biosimilars in Multiple Sclerosis

EP. 12 Generics and Biosimilars in Multiple Sclerosis

EP. 13 Emerging Treatments in Mild/Moderate Multiple Sclerosis

EP. 13 Emerging Treatments in Mild/Moderate Multiple Sclerosis

EP. 14 Final Thoughts on Caring for Patients With Mild/Moderate Multiple Sclerosis

EP. 14 Final Thoughts on Caring for Patients With Mild/Moderate Multiple Sclerosis

What does shared decision-making look like for patients with mild to moderate MS?

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Latest CME

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA, FASCO; Girish Dhall, MD

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Abigail Schwaede, MD; Alexis Lizarraga, MD, MS

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup

FDA Clears Phase 2 Trial for Demyelinating Agent Lucid-MS in Progressive Multiple Sclerosis

Ractigen Completes Enrollment for RAG-17 in SOD1-ALS, Tanruprubart Shows Rapid Responses in GBS, Building a Multidisciplinary SMA Clinic

CN045 Promotes Oligodendrocyte Maturation, Modest Remyelination in Preclinical MS Study

APOE and Polygenic Risk Shape Alzheimer Disease Onset in Extra-APP-Copy Carriers